Elite Pharmaceuticals ELTP
OTC ELTP
$0.25 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Elite Pharmaceuticals (ELTP) Cash from Operations (2010 - 2026)

Updated

Elite Pharmaceuticals' Cash from Operations came in at $10.07 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 31.8% from $14.78 million a year earlier but up 10.1% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Cash from Operations (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Elite Pharmaceuticals reported Cash from Operations of $19.04 million, down 0.2% year-over-year; for FY2026 (ended Mar 31, 2026), it was $23.75 million, up 218.5% from FY2025.

  • Cash from Operations carries a five-year compound annual growth rate of 49.4% (FY2021 to FY2026).
  • Going back by fiscal year, Cash from Operations was $7.46 million in FY2025, -$3.24 million in FY2024, $3.34 million in FY2023 (-48.7%) and $6.51 million in FY2022 (+103.8%).
  • The five-year range for quarterly Cash from Operations is -$5.28 million (fiscal Q3 2026) to $14.78 million (fiscal Q1 2026).
  • Year-over-year, Cash from Operations increased in four of the last five quarters, with growth averaging 161.7%.
  • The fastest year-over-year change in Cash from Operations over five years came in fiscal Q2 2023 (growth of 872.4%), and the weakest in fiscal Q2 2022 (a decline of 91.9%).
  • Business Quant data shows ELTP's Cash from Operations at $9.15 million (Q4 2026), -$5.28 million (Q3 2026) and $5.1 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 8.62 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 3.44 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 2.87 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 3.57 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 835.00 Mn
10 Elite Pharmaceuticals 262.85 Mn 144.52 Mn 13.51 Mn 10.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.07 Mn
Mar 31, 2026 9.15 Mn
Dec 31, 2025 -5.28 Mn
Sep 30, 2025 5.10 Mn
Jun 30, 2025 14.78 Mn
Mar 31, 2025 3.92 Mn
Dec 31, 2024 -1.06 Mn
Sep 30, 2024 1.46 Mn
Jun 30, 2024 3.14 Mn
Mar 31, 2024 2.10 Mn
Dec 31, 2023 -2.39 Mn
Sep 30, 2023 -235,938.00
Jun 30, 2023 -2.71 Mn
Mar 31, 2023 2.97 Mn
Dec 31, 2022 -567,877.00
Sep 30, 2022 1.50 Mn
Jun 30, 2022 -557,516.00
Mar 31, 2022 1.61 Mn
Dec 31, 2021 3.03 Mn
Sep 30, 2021 153,785.00
API Access

Elite Pharmaceuticals Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=ELTP&period=max&api_key=YOUR_API_KEY